NCT04960748 is a Phase 2 clinical trial of WOMEN FIGHTING TO STOP CERVICAL CANCER in Cervical Cancer Prevention, sponsored by RAND.

Who is sponsoring NCT04960748?

NCT04960748 is sponsored by RAND.

What drugs are being tested in NCT04960748?

Interventions in NCT04960748: WOMEN FIGHTING TO STOP CERVICAL CANCER.

What condition does NCT04960748 study?

NCT04960748 studies Cervical Cancer Prevention.

Is NCT04960748 still recruiting?

NCT04960748 is currently completed. Last updated 27 April 2022.

Last reviewed 2022-04-27 · How we verify

NCT04960748

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Cervical Cancer Screening Through the Advocacy of Screened Women

Completed Phase 2 Last updated 27 April 2022

What this trial tests

Phase 2 trial testing WOMEN FIGHTING TO STOP CERVICAL CANCER in Cervical Cancer Prevention in 143 participants. Completed in 25 April 2022.

Timeline

30 August 2021

Primary endpoint
25 April 2022

25 April 2022

Quick facts

Lead sponsor	RAND
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	143
Start date	30 August 2021
Primary completion	25 April 2022
Estimated completion	25 April 2022
Sites	1 location across Uganda

Drugs / interventions tested

WOMEN FIGHTING TO STOP CERVICAL CANCER

Conditions studied

Cervical Cancer Prevention — all drugs for Cervical Cancer Prevention →

Sponsor

RAND — full company profile →

Who can join

18 and older, female only, with Cervical Cancer Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study pilots a 7-session group intervention among 40 screened women, 20 of whom will be randomly assigned to take part in the intervention, and 20 to the wait-list control. Assessments will be administered at baseline and month 6 to index participants as well as up to three unscreened female social network members of each index participant (up to 120 total). The primary outcome is CC screening among participating social network members.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Social network-based group intervention to promote uptake of cervical cancer screening in Uganda: study protocol for a pilot randomized controlled trial.
Wanyenze RK, Matovu JKB, Bouskill K, Juncker M, et al · · 2022 · cited 11× · PMID 36476609 · DOI 10.1186/s40814-022-01211-z
Effects of a peer advocacy intervention on cervical cancer screening among social network members: results of a randomized controlled trial in Uganda.
Wagner GJ, Matovu JKB, Juncker M, Namisango E, et al · · 2023 · cited 9× · PMID 37702912 · DOI 10.1007/s10865-023-00418-6
Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda.
Wagner GJ, Matovu JKB, Juncker M, Namisango E, et al · · 2023 · cited 4× · PMID 37768937 · DOI 10.1158/1940-6207.capr-23-0262
Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
Matovu JK, Wagner GJ, Juncker M, Namisango E, et al · · 2023 · cited 4× · PMID 37170099 · DOI 10.1186/s12885-023-10924-0
Increased Knowledge Mediates the Effect of Game Changers for Cervical Cancer Prevention on Diffusion of Cervical Cancer Screening Advocacy Among Social Network Members in a Pilot Trial.
Ghai I, Wagner GJ, Matovu JKB, Juncker M, et al · · 2024 · PMID 37656308 · DOI 10.1007/s12529-023-10217-7

Verify or expand the search:

Other recruiting trials for Cervical Cancer Prevention

Currently open trials in the same condition.

NCT07581873 — Education and Health in Women With Cervical Cancer · NA · active not recruiting
NCT06411938 — A Cervical Cancer Prevention Program in Kenya · NA · active not recruiting

Other RAND trials

Trials by the same sponsor.

NCT06048328 — Game Changers for Family Planning Peer Advocacy Program · Phase 1, PHASE2 · not yet recruiting
NCT07072819 — Pilot of Training on 988 and Narcan · NA · completed
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
NCT06827288 — Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04960748 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RAND
Last refreshed: 27 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing